Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4929655

CNc1cc(Oc2ccc(NC(=O)Nc3ccc(CN4CCN(C(C)C)CC4)c(C(F)(F)F)c3)cc2)ncn1.O=C(O)C(F)(F)F

nearest known ligand 0.79

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 7/20 0.79
MAPK14 Q16539 6/20 0.79
TNNI3K Q59H18 6/20 0.79
SRC P12931 5/20 0.79
ABL1 P00519 5/20 0.79
MKNK2 Q9HBH9 4/20 0.79
BRAF P15056 4/20 0.79
MKNK1 Q9BUB5 3/20 0.79
RET P07949 3/20 0.79
AXL P30530 2/20 0.79
FLT3 P36888 2/20 0.79
MERTK Q12866 2/20 0.79
MAP3K7 O43318 2/20 0.79
FES P07332 2/20 0.79
HCK P08631 2/20 0.79
FER P16591 2/20 0.79
MAP4K2 Q12851 2/20 0.79
CDK2 P24941 2/20 0.79
CDK8 P49336 2/20 0.79
BCR P11274 2/20 0.79

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13991080 0.97 MAPK14 (0.84) KDRMAPK14TNNI3KSRCABL1
Trifluoroacetic Acid SCHEMBL4931474 0.89 KDR (0.73) KDRMAPK14TNNI3KSRCABL1
Ast-487 SCHEMBL29391947 0.89 HCK (1.00) KDRMAPK14TNNI3KSRCABL1
Ast-487 SCHEMBL29435006 0.89 HCK (1.00) KDRMAPK14TNNI3KSRCABL1
Ast-487 SCHEMBL1684259 0.89 HCK (1.00) KDRMAPK14TNNI3KSRCABL1
SCHEMBL4792487 0.89 SRC (0.88) KDRMAPK14TNNI3KSRCABL1
SCHEMBL4933283 0.88 SRC (0.69) KDRMAPK14TNNI3KSRCABL1
SCHEMBL4763945 0.88 KDR (0.86) KDRMAPK14TNNI3KSRCABL1
SCHEMBL4936999 0.87 SRC (0.68) KDRMAPK14TNNI3KSRCABL1
SCHEMBL4929662 0.87 HCK (0.65) KDRMAPK14TNNI3KSRCABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080312192-A1 Diaryl Urea Derivatives in the Treatment of Protein Kinase Dependent Diseases BOLD GUIDO 2008-12-18 US claimed
US-20080312192-A1 Diaryl Urea Derivatives in the Treatment of Protein Kinase Dependent Diseases BOLD GUIDO 2008-12-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080312192-A1 Diaryl Urea Derivatives in the Treatment of Protein Kinase Dependent Diseases RET, PRKDC, PRKACA KDR 1309/4885MAPK14 343/4885TNNI3K 314/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.